State Street’s CalciMedica CALC Stock Holding History

State Street’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.6K	Hold	3,415	–	–	﹤0.01%	4140
2026 Q1	$9.22K	Buy	+3,415	New	+$34.7K	﹤0.01%	4254
2023 Q1	–	Sell	-501	Closed	-$17.5K	–	4792
2022 Q4	$17.5K	Hold	501	–	–	﹤0.01%	4757
2022 Q3	$33K	Hold	501	–	–	﹤0.01%	4744
2022 Q2	$38K	Hold	501	–	–	﹤0.01%	4778
2022 Q1	$43K	Hold	501	–	–	﹤0.01%	4818
2021 Q4	$64K	Buy	501 +207	+70%	+$40.2K	﹤0.01%	4661
2021 Q3	$68K	Sell	294 -294	-50%	-$82.7K	﹤0.01%	4613
2021 Q2	$224K	Sell	588 -957	-62%	-$314K	﹤0.01%	4172
2021 Q1	$600K	Buy	1,545 +382	+33%	+$572K	﹤0.01%	3710
2020 Q4	$2.36M	Buy	+1,163	New	+$1.72M	﹤0.01%	3297

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street's CALC Position: Q2 2026 in Review

State Street held its CalciMedica (CALC) position steady in Q2 2026 at 3,415 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4140.

State Street first reported a position in CALC in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.36M in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

State Street held 3,415 shares of CalciMedica worth $17.6K as of Q2 2026.
State Street left its CalciMedica share count unchanged in Q2 2026.
CalciMedica made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4140 holding.
State Street first reported a position in CalciMedica in Q4 2020 and has held it in 11 quarters since.
State Street's CalciMedica position peaked at $2.36M in Q4 2020.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.